BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0179-2026

Medical Products Laboratories, Inc. · Philadelphia, PA

Class II Ongoing 183 days on record

Moderate impact — Class II recall โ€” temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01

Lot / code: Lot#: 71409, Expires: 02/28/2027; 71861, Expires: 08/31/2027.

Quantity: 41,328 bottles

Reason for recall

Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis

Recall record

Recall number
D-0179-2026
Classification
Class II
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
Nationwide USA
Recall initiated
2025-11-12
Classified by FDA Center
2025-11-21
FDA published
2025-12-03
Recalling firm
Medical Products Laboratories, Inc.
Firm location
Philadelphia, PA

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls